Linking Sleep Disruption to Tau Accumulation and Network Dysregulation in Early Alzheimer's Disease

睡眠中断与早期阿尔茨海默病中 Tau 蛋白积累和网络失调有关

基本信息

  • 批准号:
    10442358
  • 负责人:
  • 金额:
    $ 83.66万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-08-15 至 2025-05-31
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract: Based on animal and limited human data, sleep disruption has been linked to decreased clearance and increased production of b-amyloid and tau, proteins which in their aggregated forms represent the two hallmark pathologies seen in Alzheimer’s disease. A number of different sleep parameters have also been closely tied to memory consolidation and chronic sleep disruption increases the risk of memory impairment in older individuals. However, despite data linking sleep disruption to Alzheimer’s disease pathology and memory impairment, significant gaps remain in our understanding of how sleep disruption evolves over the course of Mild Cognitive Impairment (MCI) and what aspects of sleep may be targets for intervention. In this context, we propose to directly examine the evolution of sleep disruption in relation to the in vivo progression of tau pathology, cognitive decline, and network dysfunction. Leveraging data that suggest that tau accumulation may be quite rapid during prodromal Alzheimer’s disease, we will focus these studies on individuals with MCI. We hypothesize that disrupted sleep architecture will be closely related to increased neocortical tau pathology and cognitive impairment, both cross-sectionally and longitudinally. Further, we hypothesize that sleep disruption leads to diminished connectivity in brain networks previously linked to memory performance and cognitive decline, and that this network dysregulation may partially mediate the effects of sleep disruption on cognition. Together, these studies will improve understanding on mechanistic links between sleep, cognition, and Alzheimer’s disease. More broadly, the data from these studies will critically inform the design of interventional studies modifying sleep in early Alzheimer’s disease by identifying which specific aspects of disrupted sleep are most closely tied to b-amyloid and tau pathology (potential therapeutic targets), assessing which aspects of sleep change over time in MCI, and the extent to which longitudinal polysomnography and actigraphy can measure aspects of sleep disruption relevant to Alzheimer’s disease.
项目摘要/摘要: 基于动物和有限的人类数据,睡眠中断与清除率下降有关 增加B-淀粉样蛋白和TAU的产生,蛋白质以汇总形式代表两者 在阿尔茨海默氏病中看到的标志性病理。许多不同的睡眠参数也是 与记忆巩固和慢性睡眠中断密切相关,增加了记忆障碍的风险 老年人。但是,将睡眠中断与阿尔茨海默氏病病理学和 记忆力障碍,我们对睡眠中断如何演变的明显差距仍然存在 轻度认知障碍的过程(MCI)以及睡眠的哪些方面可能是干预的目标。在这个 上下文,我们建议直接检查与体内进展有关的睡眠破坏的演变 tau病理学,认知能力下降和网络功能障碍。利用表明tau的数据 在阿尔茨海默氏病前代疾病期间,积累可能非常迅速,我们将把这些研究重点放在 患有MCI的人。我们假设被干扰的睡眠体系结构将与增加密切相关 新皮层tau病理和认知障碍,无论是横截面还是纵向。此外,我们 假设睡眠中断导致以前链接到的大脑网络中的连通性降低 记忆表现和认知能力下降,并且该网络失调可能部分介导 睡眠破坏对认知的影响。这些研究将共同​​提高对机械的理解 睡眠,认知和阿尔茨海默氏病之间的联系。更广泛地,这些研究的数据将 批判性地告知介入研究的设计,以修改阿尔茨海默氏病的早期睡眠 干扰睡眠的哪些特定方面最紧密地与B-淀粉样蛋白和TAU病理相关(潜力) 治疗靶标),评估MCI的睡眠随时间变化的哪些方面以及多大程度上 纵向多个术语和行程学可以衡量与阿尔茨海默氏症相关的睡眠中断的各个方面 疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JASMEER P CHHATWAL其他文献

JASMEER P CHHATWAL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JASMEER P CHHATWAL', 18)}}的其他基金

Leveraging Heterogeneity in Autosomal Dominant AD to Elucidate Pathophysiology and Improve AD Biomarkers
利用常染色体显性 AD 的异质性阐明病理生理学并改善 AD 生物标志物
  • 批准号:
    10539956
  • 财政年份:
    2022
  • 资助金额:
    $ 83.66万
  • 项目类别:
Plasma tau and neurodegenerative markers as predictors of rate of AD progression
血浆 tau 蛋白和神经退行性标记物作为 AD 进展率的预测因子
  • 批准号:
    10633231
  • 财政年份:
    2021
  • 资助金额:
    $ 83.66万
  • 项目类别:
Plasma tau and neurodegenerative markers as predictors of rate of AD progression
血浆 tau 蛋白和神经退行性标记物作为 AD 进展率的预测因子
  • 批准号:
    10184985
  • 财政年份:
    2021
  • 资助金额:
    $ 83.66万
  • 项目类别:
Plasma tau and neurodegenerative markers as predictors of rate of AD progression
血浆 tau 蛋白和神经退行性标记物作为 AD 进展率的预测因子
  • 批准号:
    10491047
  • 财政年份:
    2021
  • 资助金额:
    $ 83.66万
  • 项目类别:
Linking Sleep Disruption to Tau Accumulation and Network Dysregulation in Early Alzheimer's Disease
睡眠中断与早期阿尔茨海默病中 Tau 蛋白积累和网络失调有关
  • 批准号:
    9988329
  • 财政年份:
    2019
  • 资助金额:
    $ 83.66万
  • 项目类别:
Linking Sleep Disruption to Tau Accumulation and Network Dysregulation in Early Alzheimer's Disease
睡眠中断与早期阿尔茨海默病中 Tau 蛋白积累和网络失调有关
  • 批准号:
    10629334
  • 财政年份:
    2019
  • 资助金额:
    $ 83.66万
  • 项目类别:
Age and genetic influence on fcMRI networks in autosomal dominant and sporadic AD
年龄和遗传对常染色体显性和散发性 AD 中 fcMRI 网络的影响
  • 批准号:
    9127072
  • 财政年份:
    2015
  • 资助金额:
    $ 83.66万
  • 项目类别:
Age and genetic influence on fcMRI networks in autosomal dominant and sporadic AD
年龄和遗传对常染色体显性和散发性 AD 中 fcMRI 网络的影响
  • 批准号:
    9265410
  • 财政年份:
    2015
  • 资助金额:
    $ 83.66万
  • 项目类别:
Vascular factors, physical activity, and inflammation as modulators of neurodegenerative and cognitive trajectories (Project 2)
血管因素、体力活动和炎症作为神经退行性和认知轨迹的调节剂(项目 2)
  • 批准号:
    10541811
  • 财政年份:
    2010
  • 资助金额:
    $ 83.66万
  • 项目类别:
Inhibitory interneurons: Fear conditioning/extinction
抑制性中间神经元:恐惧调节/消退
  • 批准号:
    6836231
  • 财政年份:
    2004
  • 资助金额:
    $ 83.66万
  • 项目类别:

相似海外基金

Astrocytic exocytosis of ATP in amyloid pathology and Alzheimer's disease
淀粉样蛋白病理学和阿尔茨海默病中 ATP 的星形细胞胞吐作用
  • 批准号:
    10722422
  • 财政年份:
    2023
  • 资助金额:
    $ 83.66万
  • 项目类别:
PREVENTING ALZHEIMER’S DISEASE-LIKE BRAIN PATHOLOGY IN HIV INFECTION BY TARGETING CCR5
通过靶向 CCR5 预防 HIV 感染中的阿尔茨海默病样脑部病变
  • 批准号:
    10700624
  • 财政年份:
    2023
  • 资助金额:
    $ 83.66万
  • 项目类别:
Mechanistic dissection of allosteric modulation and nonproteolytic chaperone activity of human insulin-degrading enzyme
人胰岛素降解酶变构调节和非蛋白水解伴侣活性的机制剖析
  • 批准号:
    10667987
  • 财政年份:
    2023
  • 资助金额:
    $ 83.66万
  • 项目类别:
Alzheimer's Disease and Related Dementia-like Sequelae of SARS-CoV-2 Infection: Virus-Host Interactome, Neuropathobiology, and Drug Repurposing
阿尔茨海默病和 SARS-CoV-2 感染的相关痴呆样后遗症:病毒-宿主相互作用组、神经病理生物学和药物再利用
  • 批准号:
    10661931
  • 财政年份:
    2023
  • 资助金额:
    $ 83.66万
  • 项目类别:
miR-29: A brain homeostasis molecule for Alzheimer’s disease prevention
miR-29:一种用于预防阿尔茨海默病的大脑稳态分子
  • 批准号:
    10667151
  • 财政年份:
    2023
  • 资助金额:
    $ 83.66万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了